Cardiovascular diseases are irreversible. So, it is crucial to prevent them before they appear.
Order your kit today and find out if you are developing a cardiovascular disease before it is too late.
ABOUT US
SPINOVIT is a spin-off of UCLouvain funded by Vives, B2start and SRIW.
The product and service were developed in the laboratory of Prof. Jean-Luc Balligand, Institute of Experimental and Clinical Research.
The Project Beta3_LVH funded by the European Union (Horizon 2020), a clinical trial aiming the prevention of heart failure, sustained the developement of this spin-off through the collection of samples in 9 european countries, allowing us to validate the concept developed in SPINOVIT.
The Walloon Region supported the creation of the spin-off with a First Spin-Off grant and the proof of concept through the clinical trial PICA, demonstrating the predicability of our biomarker.
THE TEAM
Nancy Van Overstraeten
Founder &
Managing Director
Jean-Luc Balligand
Scientific Advisory Board
Arvind
Soni
EPR operator
Jérôme
Linden
Clinical Trial Manager
Nathalie Fabian
EPR technician
TESTIMONIALS
"Finally, something to prevent the cardiovascular diseases"
Guy S.
"Security is just 1 mL of blood away."
Jeanine R.
"I feel safe again"
Albert V.
CONTACT
Administration:
SPINOVIT SRL
6, rue Louis de Geer
1348 Louvain-La-Neuve
Belgium
BE 078 078 4375
Lab:
57, avenue Hippocrate
1200 Bruxelles
Belgium